| For: | Abu Khalaf S, Albarrak A, Yousef M, Tahan V. Immune checkpoint inhibitors induced colitis, stay vigilant: A case report. World J Gastrointest Oncol 2020; 12(6): 699-704 [PMID: 32699584 DOI: 10.4251/wjgo.v12.i6.699] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v12/i6/699.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Dua Abuquteish, Ahmad Yousef Alazzam, Aws Khalid Abushanab, Omar Amjad Almajdoubah, Sara Aljfout, Mahmoud Taysir Mousa, Mus’ab Theeb Mustafa, Bashar Khater, Maher Sughayer. Iatrogenic effect of immune checkpoint inhibitors and targeted therapies on the lower gastrointestinal tract. Frontline Gastroenterology 2025; : flgastro-2025-103094 doi: 10.1136/flgastro-2025-103094
|
| 3 |
Shiyang Wang, Binhe Tian, Hanping Wang. Risk Factors and Prognostic Analysis of Immune Checkpoint Inhibitor-Related Colitis in Lung Cancer. Journal of Inflammation Research 2024; : 7535 doi: 10.2147/JIR.S482456
|
| 4 |
Xu Tong, Tao Zhan, Xiaoqin Dong, Dong Xu. Fever of unknown origin associated with immune checkpoint inhibitors. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1364128
|
